Live Price
Live Volume
Spyre Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $90.16 |
|---|---|
| Close | $90.25 |
| Low | $90.16 |
| Low Change | 0.00 (0.00%) |
| High | $90.25 |
| High Change | +0.09 (+0.10%) |
| Range | $0.09 |
| Volume | 2.129M |
| Dollar Volume | $192.10M |
Regular Trading Hours Yesterday
| Open | $92.84 |
|---|---|
| Close | $90.18 |
| Low | $89.85 |
| Low Change | -2.99 (-3.22%) |
| High | $93.34 |
| High Change | +0.50 (+0.54%) |
| Range | $3.49 |
| Volume | 978.732K |
| Dollar Volume | $88.26M |
Premarket Yesterday
*No Trades in Segment
Spyre Therapeutics News
1 month agoinvesting.comWhy is Spyre Therapeutics stock sliding today?
1 month agobarrons.comS&P 500 Futures Flat in Premarket Trading; Spyre Therapeutics, Intuit Lag
- 1 month agoinvesting.com
After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO
- 1 month agoinvesting.com
Spyre Therapeutics stock tumbles on trial results
- 3 months agoinvesting.com
Spyre Therapeutics stock tumbles on major insider selling
- 5 months agoinvesting.com
Spyre Therapeutics stock falls on $300M stock offering
- 5 months agoinvesting.com
Spyre Therapeutics stock surges on positive trial results
Spyre Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Spyre Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $91.17 |
|---|---|
| 10 Day Moving Average (SMA10) | $90.19 |
| 20 Day Moving Average (SMA20) | $92.61 |
| 50 Day Moving Average (SMA50) | $97.95 |
| 100 Day Moving Average (SMA100) | $88.55 |
| 200 Day Moving Average (SMA200) | $64.84 |
Spyre Therapeutics Statistics
| Average Volume (30 Days) | 1.06M |
|---|---|
| P/E Ratio (Current) | -54.52 |
| EPS (Current) | -$1.70 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$208.94M |
| Cash Ratio | 2.56 |
| Current Ratio | 18.53 |
| Quick Ratio | 18.53 |
| Debt to Equity | 0.00 |
| Enterprise Value | $8.01B |
| EV to EBITDA | -29.52 |
| EV to Sales | — |
| Price to Book | 7.42 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.13% |
| Return on Equity | -0.14% |
Spyre Therapeutics Stock Splits
There has been 1 stock split for Spyre Therapeutics (SYRE). The reverse stock split occured on September 8, 2023 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 8, 2023 | Reverse | 25:1 |
Spyre Therapeutics Dividends
There have been no dividends for Spyre Therapeutics (SYRE).